These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4398697)

  • 41. [Treatment with the preparation "Visken" (beta blocking agent) in angina pectoris].
    Mihail A; Popescu P; Petrescu X; Popa N
    Med Interna (Bucur); 1972 Aug; 24(8):925-32. PubMed ID: 4404181
    [No Abstract]   [Full Text] [Related]  

  • 42. A monitored release study. A clinical trial of oxprenolol in general practice.
    Forrest WA
    Practitioner; 1972 Mar; 208(245):412-6. PubMed ID: 4402044
    [No Abstract]   [Full Text] [Related]  

  • 43. [Remote results of treatment of angina pectoris with various types of drugs blocking beta adrenergic receptors].
    Musial W; Krzemińska-Pakula M; Tracz W
    Pol Tyg Lek; 1972 May; 27(20):752-4. PubMed ID: 4402234
    [No Abstract]   [Full Text] [Related]  

  • 44. Practolol in treatment of angina pectoris. A double-blind trial.
    George CF; Nagle RE; Pentecost BL
    Br Med J; 1970 May; 2(5706):402-4. PubMed ID: 4392984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris.
    Coltart DJ; Hamer J
    Br J Pharmacol; 1970 Sep; 40(1):147P-148P. PubMed ID: 4395080
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of the symptomatic, electrocardiographic and haemodynamic effects of acute and long term -blockade in angina pectoris.
    Sharma B; Taylor SH
    Br J Pharmacol; 1971 Oct; 43(2):470P-471P. PubMed ID: 4400578
    [No Abstract]   [Full Text] [Related]  

  • 47. [A cardio-selective beta blockader: practolol].
    Biron P
    Union Med Can; 1971 May; 100(5):973-4. PubMed ID: 4147302
    [No Abstract]   [Full Text] [Related]  

  • 48. Beta adrenergic blocking agents for exertional angina pectoris.
    Thadani U
    Herz; 1982 Jun; 7(3):179-87. PubMed ID: 6124493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ambulatory therapy of arrhythmias using practolol].
    Klaus D; Winkler H
    Med Welt; 1972 Nov; 23(47):1775-8. PubMed ID: 4404707
    [No Abstract]   [Full Text] [Related]  

  • 50. Practolol in the treatment of ischaemic heart pain. Results of a controlled trial.
    Nestel PJ
    Med J Aust; 1972 May; 1(20):1033-5. PubMed ID: 4626799
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm.
    Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén HN
    Cardiologia; 1995 Dec; 40(12 Suppl 1):301. PubMed ID: 8903053
    [No Abstract]   [Full Text] [Related]  

  • 52. Practolol (Eraldin) eye drops as an ocular hypotensive agent.
    Vale J; Phillips CI
    Br J Ophthalmol; 1973 Mar; 57(3):210-4. PubMed ID: 4145269
    [No Abstract]   [Full Text] [Related]  

  • 53. Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol.
    Dagenais GR; Pitt B; Ross RS
    Am J Cardiol; 1971 Jul; 28(1):10-6. PubMed ID: 4397511
    [No Abstract]   [Full Text] [Related]  

  • 54. [Preliminary experience with practolol (ICI 50172, Eraldin) in the treatment of cardiac arrhythmias].
    Telerman M; Lebedelle M; de Valeriola Y
    Acta Cardiol; 1972; Suppl 16():55-8. PubMed ID: 4405745
    [No Abstract]   [Full Text] [Related]  

  • 55. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial.
    Hickie JB
    Med J Aust; 1970 Aug; 2(6):268-72. PubMed ID: 4393977
    [No Abstract]   [Full Text] [Related]  

  • 56. [Controlled study of the beta-receptor blockader Kö 592 in patients with angina pectoris].
    Lerche D
    Dtsch Med J; 1971 Jul; 22(14):455-62. PubMed ID: 4398040
    [No Abstract]   [Full Text] [Related]  

  • 57. [Beta adrenergic receptor blockaders in treatment of angina pectoris. A critical evaluation].
    Lukasik S; Wrabec K; Stańkowska K; Janicka K
    Pol Tyg Lek; 1973 Jan; 28(1):17-20. PubMed ID: 4405580
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diagnosis and treatment of acute coronary insufficiency. A propos of 6 cases].
    Buonanno C; Mancuso M; Zanini S; Besa G; Poppi A
    G Ital Cardiol; 1972; 2(6):893-906. PubMed ID: 4636258
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of beta-adrenolytic agent in the treatment of angina pectoris].
    De Vita C; Cadel A; Carú B; Mazzini C; Parenti GF
    Minerva Cardioangiol; 1973 Apr; 21(4):304-16. PubMed ID: 4145467
    [No Abstract]   [Full Text] [Related]  

  • 60. [Practolol (Eraldin) and ischemic heart disease. An ergometric study].
    Bjerregaard P; Hvidt S
    Ugeskr Laeger; 1971 Jan; 133(2):49-53. PubMed ID: 4395835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.